INTRODUCTION: Atrial fibrillation is a supraventricular tachyarrhythmia characterised by the presence of fast and uncoordinated atrial activation leading to reduced atrial mechanical function. Risk factors for atrial fibrillation include increasing age, male sex, co-existing cardiac and thyroid disease, pyrexial illness, electrolyte imbalance, cancer, and co-existing infection. METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical question: What are the effects of oral medical treatments to control heart rate in people with chronic (defined as longer than 1 week for this review) non-valvular atrial fibrillation? We searched: Medline, Embase, The Cochrane Library, and other important databases up to May 2014 (Clinical Evidence reviews are updated periodically; please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA). RESULTS: We found four studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions. CONCLUSIONS: In this systematic review we present information relating to the effectiveness and safety of the following interventions: beta-blockers (rate-limiting, with or without digoxin), calcium-channel blockers (with or without digoxin), and digoxin.
INTRODUCTION:Atrial fibrillation is a supraventricular tachyarrhythmia characterised by the presence of fast and uncoordinated atrial activation leading to reduced atrial mechanical function. Risk factors for atrial fibrillation include increasing age, male sex, co-existing cardiac and thyroid disease, pyrexial illness, electrolyte imbalance, cancer, and co-existing infection. METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical question: What are the effects of oral medical treatments to control heart rate in people with chronic (defined as longer than 1 week for this review) non-valvular atrial fibrillation? We searched: Medline, Embase, The Cochrane Library, and other important databases up to May 2014 (Clinical Evidence reviews are updated periodically; please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA). RESULTS: We found four studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions. CONCLUSIONS: In this systematic review we present information relating to the effectiveness and safety of the following interventions: beta-blockers (rate-limiting, with or without digoxin), calcium-channel blockers (with or without digoxin), and digoxin.
Authors: Yoko Miyasaka; Marion E Barnes; Bernard J Gersh; Stephen S Cha; Kent R Bailey; Walter P Abhayaratna; James B Seward; Teresa S M Tsang Journal: Circulation Date: 2006-07-03 Impact factor: 29.690
Authors: F D R Hobbs; D A Fitzmaurice; J Mant; E Murray; S Jowett; S Bryan; J Raftery; M Davies; G Lip Journal: Health Technol Assess Date: 2005-10 Impact factor: 4.014
Authors: K K Koh; J H Song; K S Kwon; H B Park; S H Baik; Y S Park; H H In; T H Moon; G S Park; S K Cho Journal: Int J Cardiol Date: 1995-11-24 Impact factor: 4.164
Authors: Aleem U Khand; Andrew C Rankin; William Martin; Jacqueline Taylor; Islay Gemmell; John G F Cleland Journal: J Am Coll Cardiol Date: 2003-12-03 Impact factor: 24.094
Authors: Robby Nieuwlaat; Luc W Eurlings; John G Cleland; Stuart M Cobbe; Panos E Vardas; Alessandro Capucci; José L López-Sendòn; Joan G Meeder; Yigal M Pinto; Harry J G M Crijns Journal: J Am Coll Cardiol Date: 2009-05-05 Impact factor: 24.094
Authors: Sara R Ulimoen; Steve Enger; Jonas Carlson; Pyotr G Platonov; Are H Pripp; Michael Abdelnoor; Harald Arnesen; Knut Gjesdal; Arnljot Tveit Journal: Am J Cardiol Date: 2012-10-27 Impact factor: 2.778
Authors: Jan Heeringa; Deirdre A M van der Kuip; Albert Hofman; Jan A Kors; Gerard van Herpen; Bruno H Ch Stricker; Theo Stijnen; Gregory Y H Lip; Jacqueline C M Witteman Journal: Eur Heart J Date: 2006-03-09 Impact factor: 29.983
Authors: Lindsay J Young; Steve Antwi-Boasiako; Joel Ferrall; Loren E Wold; Peter J Mohler; Mona El Refaey Journal: Life Sci Date: 2022-04-03 Impact factor: 6.780
Authors: Giulio Musotto; Alessandra Monteleone; Danila Vella; Sofia Di Leonardo; Alessia Viola; Giuseppe Pitarresi; Bernardo Zuccarello; Antonio Pantano; Andrew Cook; Giorgia M Bosi; Gaetano Burriesci Journal: Front Cardiovasc Med Date: 2022-07-14